These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 32334645)
1. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Isidori AM; Pofi R; Hasenmajer V; Lenzi A; Pivonello R Lancet Diabetes Endocrinol; 2020 Jun; 8(6):472-473. PubMed ID: 32334645 [No Abstract] [Full Text] [Related]
2. COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency? Scaroni C; Armigliato M; Cannavò S J Endocrinol Invest; 2020 Jul; 43(7):1035-1036. PubMed ID: 32300975 [No Abstract] [Full Text] [Related]
3. Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan. Tu WJ; Cao J; Yu L; Hu X; Liu Q Intensive Care Med; 2020 Jun; 46(6):1117-1120. PubMed ID: 32253448 [No Abstract] [Full Text] [Related]
4. Successful use of methylprednisolone for treating severe COVID-19. Liu J; Zheng X; Huang Y; Shan H; Huang J J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759 [No Abstract] [Full Text] [Related]
5. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Pal R Endocrine; 2020 May; 68(2):251-252. PubMed ID: 32346813 [No Abstract] [Full Text] [Related]
6. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. Isidori AM; Arnaldi G; Boscaro M; Falorni A; Giordano C; Giordano R; Pivonello R; Pofi R; Hasenmajer V; Venneri MA; Sbardella E; Simeoli C; Scaroni C; Lenzi A J Endocrinol Invest; 2020 Aug; 43(8):1141-1147. PubMed ID: 32335855 [No Abstract] [Full Text] [Related]
7. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening. Tavazzi G; Civardi L; Caneva L; Mongodi S; Mojoli F Intensive Care Med; 2020 Jun; 46(6):1121-1123. PubMed ID: 32322918 [No Abstract] [Full Text] [Related]
8. Is COVID-19 more severe in older men? Liang X Postgrad Med J; 2020 Jul; 96(1137):426. PubMed ID: 32404490 [No Abstract] [Full Text] [Related]
9. Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic. Almeida MQ; Mendonca BB Clinics (Sao Paulo); 2020; 75():e2022. PubMed ID: 32555949 [TBL] [Abstract][Full Text] [Related]
10. May IL-17 have a role in COVID-19 infection? Megna M; Napolitano M; Fabbrocini G Med Hypotheses; 2020 Jul; 140():109749. PubMed ID: 32339777 [No Abstract] [Full Text] [Related]
11. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Joly BS; Siguret V; Veyradier A Intensive Care Med; 2020 Aug; 46(8):1603-1606. PubMed ID: 32415314 [No Abstract] [Full Text] [Related]
12. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy. Chrousos GP; Meduri GU Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524 [No Abstract] [Full Text] [Related]
13. Pros and cons of corticosteroid therapy for COVID-19 patients. Mattos-Silva P; Felix NS; Silva PL; Robba C; Battaglini D; Pelosi P; Rocco PRM; Cruz FF Respir Physiol Neurobiol; 2020 Sep; 280():103492. PubMed ID: 32659271 [TBL] [Abstract][Full Text] [Related]
15. On the genetics and immunopathogenesis of COVID-19. Jacob CO Clin Immunol; 2020 Nov; 220():108591. PubMed ID: 32920210 [TBL] [Abstract][Full Text] [Related]
16. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency. Arlt W; Baldeweg SE; Pearce SHS; Simpson HL Eur J Endocrinol; 2020 Jul; 183(1):G25-G32. PubMed ID: 32379699 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report. Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448 [No Abstract] [Full Text] [Related]
18. Immunosuppression drug advice and COVID-19: are we doing more harm than good? Warraich R; Amani L; Mediwake R; Tahir H Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589546 [TBL] [Abstract][Full Text] [Related]
19. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19. Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of inflammatory response in associated comorbidities in COVID-19. de Lucena TMC; da Silva Santos AF; de Lima BR; de Albuquerque Borborema ME; de Azevêdo Silva J Diabetes Metab Syndr; 2020; 14(4):597-600. PubMed ID: 32417709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]